Dwayne Johnson gynecomastia surgery has become a widely searched topic, reflecting broader public curiosity about gynaecomastia — the benign enlargement of glandular breast tissue in males. While celebrity speculation can spark interest, clinical decisions should always be grounded in medical evidence. Gynaecomastia is a common condition affecting males of all ages, caused by hormonal imbalance, medications, or underlying health conditions. This article explains what gynaecomastia is, who it affects, the surgical options available in the UK, what to expect from treatment, and how to access care safely through NHS or private pathways.

What Is Gynaecomastia and Who Does It Affect?

Gynaecomastia is benign glandular breast tissue enlargement in males caused by oestrogen-testosterone imbalance, affecting up to 60% of adolescent boys and increasing in prevalence again after age 50.

Gynaecomastia is the benign enlargement of glandular breast tissue in males, resulting in a visibly fuller or more prominent chest. It is a common condition that can affect males at any age, from newborns and adolescents to older adults. It is estimated to affect around 50–60% of adolescent boys during puberty, though it often resolves naturally within a few years without treatment. In adult men, prevalence increases again with age, particularly in those over 50.

It is important to distinguish true gynaecomastia — which involves proliferation of glandular breast tissue — from pseudogynaecomastia, where chest fullness is caused by excess fatty tissue without glandular enlargement. Pseudogynaecomastia is commonly associated with obesity and may improve significantly with weight loss alone.

True gynaecomastia arises from an imbalance between oestrogen and testosterone, which stimulates glandular tissue growth. Common causes include:

• Hormonal changes during puberty or ageing

• Medications — including anabolic steroids, anti-androgens (e.g., bicalutamide, finasteride, dutasteride), spironolactone, GnRH analogues, cimetidine, ketoconazole, digoxin, and some antiretrovirals; certain antidepressants have also been associated, though evidence is limited

• Underlying health conditions including liver disease, chronic kidney disease, hyperthyroidism, hypogonadism, or hCG-secreting tumours (e.g., testicular tumours)

• Recreational drug use, including cannabis and anabolic steroids

• Obesity and alcohol misuse, which can alter sex hormone metabolism

It is worth noting that public interest in gynaecomastia surgery is sometimes driven by celebrity speculation — including discussions around public figures such as Dwayne Johnson. However, there is no official confirmation or verified clinical information linking him to any such procedure. Such speculation should not be used as a basis for personal medical decisions. What matters clinically is understanding the condition on its own medical merits.

Gynaecomastia can cause significant psychological distress, including reduced self-esteem and social anxiety. Men should seek a GP assessment if they notice breast tenderness, rapid growth, or unilateral swelling. The following features are red flags requiring prompt referral:

• A hard, irregular, or fixed unilateral breast mass

• Nipple discharge, retraction, or skin tethering

• Palpable axillary lymph nodes

• Any associated testicular mass or abnormality

Under NICE guidance (NG12: Suspected cancer — recognition and referral), an unexplained breast lump in a male aged 30 or over, or unilateral nipple changes in a male aged 50 or over, should be referred via the 2-week-wait pathway to exclude malignancy. Any suspected testicular mass should prompt urgent urology referral. Although breast cancer is uncommon in men, it requires prompt investigation. Suspected side effects from any medicine thought to be causing gynaecomastia should be reported to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk).

Surgical Treatment Options for Gynaecomastia in the UK

UK surgeons use liposuction, subareolar gland excision, or a combined approach depending on tissue composition and grade; surgery is appropriate only after conservative measures and underlying causes have been addressed.

When gynaecomastia does not resolve spontaneously and causes significant physical or psychological impact, surgical intervention may be considered. Surgery is generally most appropriate once the condition has been stable for at least six to twelve months, puberty is complete, any underlying causes have been addressed, and weight has been stabilised. Non-surgical approaches — including watchful waiting, treating reversible causes, and weight management — should be explored first.

In the UK, two primary surgical approaches are used, often in combination depending on the composition and grade of the breast tissue:

• Liposuction: Suitable when excess fatty tissue is the predominant component. A small cannula is inserted through a minor incision to remove fat, leaving minimal scarring. This is often performed under local or general anaesthesia.

• Subareolar gland excision (subcutaneous mastectomy): Required when firm, fibrous glandular tissue is present beneath the nipple-areola complex. This involves a small incision, typically along the lower border of the areola, to remove the glandular disc directly. In higher-grade cases with significant skin redundancy, peri-areolar skin excision or mastopexy techniques may also be required.

• Combined approach: Many surgeons use both techniques simultaneously to achieve a flatter, more contoured chest result, particularly in moderate-to-severe cases.

Gynaecomastia is graded using classification systems such as the Simon or Rohrich grading. The Simon classification describes Grade I (minor enlargement, no skin excess), Grade IIa (moderate enlargement, no skin excess), Grade IIb (moderate enlargement with minor skin excess), and Grade III (marked enlargement with significant skin redundancy). These grades help surgeons determine the most appropriate surgical technique.

In the UK, this surgery is most commonly performed by consultant plastic surgeons or specialist cosmetic surgeons. Patients should ensure their surgeon is on the GMC Specialist Register (ideally in Plastic Surgery) and has demonstrable experience in chest contouring procedures. Membership of BAAPS (British Association of Aesthetic Plastic Surgeons) or BAPRAS (British Association of Plastic, Reconstructive and Aesthetic Surgeons) provides an additional quality marker. The facility should be registered with and inspected by the Care Quality Commission (CQC); patients can verify this at cqc.org.uk. Choosing a qualified, regulated practitioner working in a CQC-registered facility is essential for patient safety and optimal outcomes.

What to Expect Before, During and After Surgery

Pre-operative assessment includes targeted blood tests, medication review, and informed consent with a cooling-off period; recovery involves wearing a compression garment for 4–6 weeks, with final results visible at 3–6 months.

A thorough pre-operative assessment is essential before any surgical procedure for gynaecomastia. This typically includes a detailed medical history, physical examination, and targeted investigations based on clinical findings. Routine blanket hormone testing is not always indicated — for example, in classic pubertal gynaecomastia without red flags, extensive investigation may not be necessary. Where clinically indicated, your surgeon or GP may request:

• Blood tests to assess hormone levels (testosterone, LH, FSH, oestradiol, prolactin, TSH), liver function, and renal function; serum hCG should be measured if a tumour is suspected

• Testicular examination and ultrasound where a testicular abnormality is identified or suspected

• Ultrasound or mammography if there is clinical concern about the nature of the breast tissue

• Medication review, including discussion with the prescribing clinician regarding anticoagulants, antiplatelets, NSAIDs, and certain herbal supplements (e.g., fish oil, ginkgo), which may need to be paused prior to surgery

Patients are advised to stop smoking at least six weeks before surgery, as smoking significantly impairs wound healing and increases anaesthetic risk. A pre-operative consultation will include a discussion of realistic expectations, photographic documentation, and written informed consent — a requirement under GMC guidance. A cooling-off period between consultation and surgery is recommended in line with GMC guidance on cosmetic interventions.

VTE (venous thromboembolism) risk should be formally assessed pre-operatively. Early mobilisation after surgery, and the use of compression stockings or pharmacological prophylaxis where indicated, are important safety measures.

The procedure itself typically lasts between one and two hours and is most commonly performed under general anaesthesia, though local anaesthesia with sedation may be used for minor cases. Patients are usually discharged on the same day or after one night's stay.

In the immediate post-operative period, patients can expect:

• Swelling and bruising around the chest, which may persist for several weeks

• A compression garment worn continuously for four to six weeks to support healing and reduce oedema

• Drain tubes in some cases, removed within 24–48 hours

• Restricted arm movement and avoidance of strenuous activity for four to six weeks

Practical aftercare guidance includes: keeping wounds clean and dry until healed, avoiding swimming until wounds have fully closed, refraining from driving until pain-free and able to perform an emergency stop, and returning to gym or physical activity gradually from four to six weeks as advised by your surgeon. Scar care — including sun protection and silicone therapy for those at higher risk of hypertrophic or keloid scarring — should be maintained for up to twelve months.

Final results are typically visible at three to six months once swelling has fully resolved. Most patients report high satisfaction rates, with significant improvements in body image and quality of life following successful surgery.

Risks, Recovery and NHS or Private Pathways

Risks include scarring, asymmetry, haematoma, and recurrence if the underlying cause is untreated; NHS funding is rarely granted, with most procedures performed privately at £3,000–£6,000.

As with all surgical procedures, gynaecomastia surgery carries a range of potential risks. Patients should be fully informed of these during the consent process. Risks include:

• Scarring: Usually minimal and well-concealed, but individual healing varies; hypertrophic or keloid scarring may occur, particularly in those with a personal or family history

• Asymmetry: Minor differences between sides are common; significant asymmetry may require revision surgery

• Changes in nipple sensation: Temporary or, rarely, permanent numbness or hypersensitivity

• Nipple or areolar necrosis: Rare but serious; risk is higher in more extensive procedures

• Nipple inversion or areolar distortion: May occur following gland excision

• Crater deformity: Over-resection of tissue beneath the nipple can result in a depressed contour

• Haematoma or seroma: Accumulation of blood or fluid beneath the skin, which may require drainage

• Infection: Managed with antibiotics; rare with proper surgical technique

• Delayed wound healing: More common in smokers or those with diabetes

• Contour irregularities: Particularly following liposuction, including skin dimpling

• Persistent pain: Uncommon but possible

• VTE (deep vein thrombosis or pulmonary embolism): A recognised risk of any surgical procedure under general anaesthesia

• Anaesthetic risks: Including allergic reactions and, very rarely, serious cardiorespiratory events

• Recurrence: Gynaecomastia may recur if the underlying cause (e.g., anabolic steroid use, causative medication, hormonal imbalance) is not addressed

Recovery timelines vary by individual and procedure complexity. Most patients return to desk-based work within one to two weeks, whilst physical labour or gym activity should be avoided for at least four to six weeks. Follow-up appointments are typically scheduled at one week, six weeks, and three months post-operatively.

NHS funding for gynaecomastia surgery is generally limited. NHS England's Evidence-Based Interventions (EBI) programme classifies male breast reduction as a procedure that should not be routinely commissioned, and most NHS Integrated Care Boards (ICBs) have local policies restricting funding. Funding may be considered in exceptional circumstances — for example, where there is documented severe psychological impact or an identifiable underlying medical cause. Patients should discuss eligibility with their GP, who can submit an Individual Funding Request (IFR) to the relevant ICB if appropriate.

The majority of gynaecomastia surgeries in the UK are performed privately. Costs typically range from £3,000 to £6,000 depending on the complexity of the procedure and the surgeon's experience. Patients are strongly advised to avoid choosing a provider based solely on cost, and to verify surgeon credentials through the GMC register and facility registration through the CQC.

When to seek urgent help: If at any point post-operatively a patient experiences uncontrolled bleeding, severe or worsening chest pain, sudden breathlessness, or signs of serious infection (high fever, spreading redness, wound breakdown), they should call 999 or attend A&E immediately. For less urgent concerns, contact your surgical team directly. Suspected side effects from any medicine or medical device should be reported to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk).

Experiencing these side effects? Our pharmacists can help you navigate them →

Frequently Asked Questions